- Home
- RVNC vs SMBC Comparison
RVNC vs SMBC Comparison
Compare RVNC & SMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVNC
- SMBC
- Stock Information
- Founded
- RVNC 1999
- SMBC 1887
- Country
- RVNC United States
- SMBC United States
- Employees
- RVNC N/A
- SMBC N/A
- Industry
- RVNC Biotechnology: Pharmaceutical Preparations
- SMBC Banks
- Sector
- RVNC Health Care
- SMBC Finance
- Exchange
- RVNC Nasdaq
- SMBC Nasdaq
- Market Cap
- RVNC 599.6M
- SMBC 678.4M
- IPO Year
- RVNC 2014
- SMBC N/A
- Fundamental
- Price
- RVNC $5.78
- SMBC $63.81
- Analyst Decision
- RVNC Buy
- SMBC Buy
- Analyst Count
- RVNC 10
- SMBC 3
- Target Price
- RVNC $10.86
- SMBC $63.00
- AVG Volume (30 Days)
- RVNC 1.6M
- SMBC 34.0K
- Earning Date
- RVNC 11-19-2024
- SMBC 10-28-2024
- Dividend Yield
- RVNC N/A
- SMBC 1.43%
- EPS Growth
- RVNC N/A
- SMBC 9.21
- EPS
- RVNC N/A
- SMBC 4.36
- Revenue
- RVNC $251,178,000.00
- SMBC $162,056,000.00
- Revenue This Year
- RVNC $20.36
- SMBC N/A
- Revenue Next Year
- RVNC $31.66
- SMBC $8.26
- P/E Ratio
- RVNC N/A
- SMBC $14.78
- Revenue Growth
- RVNC 40.23
- SMBC 10.04
- 52 Week Low
- RVNC $2.30
- SMBC $39.00
- 52 Week High
- RVNC $9.75
- SMBC $67.67
- Technical
- Relative Strength Index (RSI)
- RVNC 56.47
- SMBC 61.25
- Support Level
- RVNC $5.67
- SMBC $57.41
- Resistance Level
- RVNC $5.97
- SMBC $67.67
- Average True Range (ATR)
- RVNC 0.19
- SMBC 1.80
- MACD
- RVNC 0.06
- SMBC 0.41
- Stochastic Oscillator
- RVNC 78.01
- SMBC 64.78
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.
About SMBC Southern Missouri Bancorp Inc.
Southern Missouri Bancorp Inc is a us-based holding company for Southern Missouri Savings Bank. The principal business of the bank consists of attracting retail deposits from the general public and using such deposits along with wholesale funding from the Federal Home Loan Bank of Des Moines, and to a lesser extent, brokered deposits, to invest in one- to four-family residential mortgage loans, mortgage loans secured by commercial real estate, commercial non-mortgage business loans, and consumer loans. It is engaged in providing the range of banking and financial services to individuals and corporate customers in its market areas. The company derives revenue principally from interest earned on loans, debt securities, bank card interchange fees, loan late charges and another fee income.